V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009292 | 190004861 | 1.67 | 79.5 | Curative (C) | 2017-10-02 | 2018-03-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | CISPLATIN + GEMCITABINE | 100616386 |
| 190009293 | 190004862 | 1.71 | 79.4 | Curative (C) | 2018-05-24 | 2018-06-22 | ETOPOSIDE | 02 | null | CARBOPLATIN + GEMCITABINE | 101577436 |
| 190009303 | 190004863 | 1.74 | 48.7 | 03 | 2017-05-31 | 2017-05-31 | Paclitaxel 7 day | 99 | N | PEMBROLIZUMAB | 101014159 |
| 190009305 | 190004864 | 1.6 | 0 | Curative (C) | 2019-01-29 | 2019-02-20 | null | 02 | Y | PACLITAXEL | 101481810 |
| 190009313 | 190004865 | 1.78 | 54.8 | null | 2020-02-25 | 2020-03-15 | Capecitabine + Oxaliplatin 21day | 02 | null | CISPLATIN + GEMCITABINE | 100069593 |
| 190009314 | 190004866 | 1.83 | 45.3 | Curative (C) | 2017-05-31 | 2017-08-02 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101072272 |
| 190009315 | 190004867 | 1.58 | null | null | 2021-04-25 | 2021-04-27 | Carboplatin + Etoposide iv&po | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100987342 |
| 190009319 | 190004868 | 1.63 | 65 | Curative (C) | 2017-02-07 | 2017-07-06 | IMATINIB | null | null | CAPECITABINE | 100467055 |
| 190009322 | 190004869 | 1.89 | 87 | null | 2018-05-13 | 2018-05-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | CARBOPLATIN + PACLITAXEL | 100420074 |
| 190009326 | 190004870 | 1.61 | 69.4 | Neo-adjuvant (N) | 2016-11-05 | 2017-06-15 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100858772 |
| 190009329 | 190004871 | 1.62 | 98.1 | Curative (C) | 2019-04-07 | 2019-04-12 | Doxorubicin + Ifosfamide | 02 | N | PACLITAXEL | 100062057 |
| 190009332 | 190004872 | 0 | 36.9 | Palliative (P) | 2020-06-13 | 2020-07-05 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100433526 |
| 190009336 | 190004873 | 1.48 | 68.1 | null | null | 2019-05-01 | Cyclophosphamide High Dose | 02 | N | CAPECITABINE | 100703600 |
| 190009337 | 190004874 | 1.75 | 59 | null | 2019-02-28 | 2019-03-08 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100926469 |
| 190009340 | 190004875 | 1.7 | 51.8 | null | 2021-08-16 | 2021-09-08 | EURAMOS TRIAL | null | null | PACLITAXEL | 101125216 |
| 190009344 | 190004876 | 1.69 | 74.65 | Palliative (P) | 2018-04-16 | 2018-04-20 | VAI (Ifos 3g/m2) | 02 | null | CAPECITABINE + CARBOPLATIN | 101770209 |
| 190009351 | 190004878 | 1.82 | 41.3 | null | 2019-01-16 | 2019-01-24 | CARBOPLATIN + PACLITAXEL | N | null | CARBOPLATIN + PACLITAXEL | 100077163 |
| 190009357 | 190004879 | 1.71 | 82 | Neo-adjuvant (N) | 2018-12-16 | 2018-12-23 | TEMOZOLOMIDE | N | N | CISPLATIN + RT | 101866940 |
| 190009359 | 190004880 | 1.8 | 54.2 | null | 2017-11-12 | 2017-11-28 | Trial Unspecified | 02 | N | AVELUMAB | 100505515 |
| 190009360 | 190004881 | 1.66 | 10.3 | null | 2018-07-13 | 2019-12-28 | CARBOPLATIN + ETOPOSIDE | null | null | CISPLATIN + ETOPOSIDE | 101313484 |
| 190009362 | 190004882 | 1.64 | 77.7 | Palliative (P) | 2018-09-30 | 2019-03-31 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101698984 |
| 190009364 | 190004883 | 1.6 | 45 | Neo-adjuvant (N) | 2017-04-28 | 2017-11-25 | CISPLATIN + GEMCITABINE | 02 | N | BEVACIZUMAB | 100694368 |
| 190009365 | 190004884 | 1.56 | 47.5 | Adjuvant (A) | 2015-09-16 | 2015-09-21 | Paclitaxel 7 day | 1 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101285967 |
| 190009375 | 190004886 | 1.59 | 86.6 | null | null | 2018-02-22 | CAPECITABINE + IRINOTECAN | null | null | GEMCITABINE | 101571506 |
| 190009383 | 190004887 | 1.64 | 111 | Adjuvant (A) | 2019-12-30 | 2020-01-09 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101263645 |
| 190009391 | 190004888 | null | 59.9 | null | 2021-03-18 | 2021-04-03 | VAI (Ifos 3g/m2) | N | N | CARBOPLATIN + ETOPOSIDE | 100856565 |
| 190009394 | 190004889 | 1.6 | 59.3 | null | null | 2020-01-05 | CAPECITABINE + OXALIPLATIN | null | null | FLUOROURACIL + IRINOTECAN | 101428911 |
| 190009395 | 190004890 | 1.77 | 53.1 | Neo-adjuvant (N) | 2016-07-17 | 2016-07-20 | Cyclophosphamide + Topotecan | 99 | N | CISPLATIN + FLUOROURACIL | 100366699 |
| 190009396 | 190004891 | 1.72 | 102.2 | Curative (C) | 2018-08-18 | 2018-08-22 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101470043 |
| 190009397 | 190004892 | 0 | 51 | Curative (C) | 2016-10-29 | 2016-11-06 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CISPLATIN + DOCETAXEL | 100097636 |
| 190009401 | 190004893 | 1.51 | 56.7 | null | 2018-03-06 | 2018-08-28 | Irinotecan + Temozolomide | 02 | N | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 100140623 |
| 190009405 | 190004894 | 0 | 51.1 | 03 | 2018-04-20 | 2019-01-29 | EURAMOS TRIAL | Y | N | PACLITAXEL | 101728198 |
| 190009408 | 190004895 | 1.8 | 59.5 | Curative (C) | 2021-05-15 | 2021-06-05 | Cyclophosphamide + Topotecan | Y | Y | CISPLATIN + RT | 100768830 |
| 190009412 | 190004896 | 1.89 | 66.5 | null | 2017-09-16 | 2017-09-23 | CISPLATIN + RT | 02 | Y | CISPLATIN | 100861683 |
| 190009413 | 190004897 | 1.72 | null | Adjuvant (A) | null | 2018-05-12 | Cisplatin 7 day | 02 | null | CISPLATIN | 101511972 |
| 190009415 | 190004898 | null | 46.8 | Curative (C) | 2019-05-14 | 2019-06-18 | Doxorubicin + Olaratumab | 01 | N | CAPECITABINE | 100285785 |
| 190009416 | 190004899 | 1.74 | 55.9 | null | 2018-07-21 | 2018-07-21 | MAP | 02 | N | CARBOPLATIN + ETOPOSIDE | 101804731 |
| 190009427 | 190004900 | 0 | 59.8 | Curative (C) | 2019-05-11 | 2019-05-21 | Doxorubicin + Olaratumab | 02 | N | LIPOSOMAL DOXORUBICIN | 101183051 |
| 190009428 | 190004901 | 1.79 | 100.25 | null | 2021-09-19 | 2021-09-29 | OST Euramos 1 Closed Trial - M | 02 | N | CISPLATIN + RT | 101159450 |
| 190009431 | 190004902 | null | 70 | Curative (C) | null | 2020-01-22 | CARBOPLATIN + RT | null | null | CARBOPLATIN | 100098831 |
| 190009436 | 190004903 | 1.77 | 38.25 | Adjuvant (A) | 2018-12-21 | 2018-12-27 | Etoposide oral | 02 | null | ETOPOSIDE | 101506781 |
| 190009440 | 190004904 | null | 105.2 | Neo-adjuvant (N) | 2018-04-21 | 2018-04-24 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100102281 |
| 190009444 | 190004905 | 1.76 | 68.3 | Adjuvant (A) | 2018-07-25 | 2019-02-07 | Ifosfamide | null | null | CISPLATIN + FLUOROURACIL | 101018667 |
| 190009449 | 190004906 | 0 | 45.8 | 03 | 2019-03-25 | 2019-07-16 | NIVOLUMAB | N | Y | STS NON-RHABDO EPSSG 2005 VDC/IE | 101848028 |
| 190009459 | 190004907 | 1.65 | 48.4 | null | 2018-07-13 | 2018-07-17 | Carboplatin + Etoposide IV 3 day | null | null | CAPECITABINE + MITOMYCIN | 101373999 |
| 190009462 | 190004908 | 1.57 | 74 | Palliative (P) | 2020-03-22 | 2020-04-12 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101653072 |
| 190009468 | 190004909 | 1.73 | 62 | Curative (C) | 2016-12-11 | 2017-01-12 | VAI (Ifos 3g/m2) | 02 | Y | ENZALUTAMIDE | 100891838 |
| 190009469 | 190004910 | 1.72 | 73 | Curative (C) | 2017-10-17 | 2017-10-17 | LANREOTIDE | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100346219 |
| 190009470 | 190004911 | 1.5 | 54.3 | Curative (C) | 2019-11-03 | 2019-11-23 | Cisplatin 100 + RT(H&N) 1 day | 02 | Y | CISPLATIN | 101465824 |
| 190009473 | 190004912 | 1.65 | null | null | null | 2020-09-19 | EURAMOS TRIAL | 99 | N | TOPOTECAN | 100708468 |